.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Boehringer Ingelheim
Express Scripts
AstraZeneca
Baxter
Fish and Richardson
QuintilesIMS
Cantor Fitzgerald
Farmers Insurance
US Department of Justice

Generated: September 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078457

« Back to Dashboard
NDA 078457 describes QUINAPRIL HYDROCHLORIDE, which is a drug marketed by Sun Pharm Inds Ltd, Sandoz, Teva, Prinston Inc, Aurobindo Pharma Ltd, Mylan, Apotex Inc, Actavis Labs Fl Inc, Invagen Pharms, Actavis Elizabeth, Lupin, Apotex Corp, and Aurobindo Pharma, and is included in eighteen NDAs. It is available from seventeen suppliers. Additional details are available on the QUINAPRIL HYDROCHLORIDE profile page.

The generic ingredient in QUINAPRIL HYDROCHLORIDE is hydrochlorothiazide; quinapril hydrochloride. There are thirty-one drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; quinapril hydrochloride profile page.

Summary for NDA: 078457

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 078457

Suppliers and Packaging for NDA: 078457

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
QUINAPRIL HYDROCHLORIDE
quinapril hydrochloride
TABLET;ORAL 078457 ANDA Camber Pharmaceuticals, Inc. 31722-267 31722-267-10 24 BOTTLE in 1 CASE (31722-267-10) > 1000 TABLET in 1 BOTTLE
QUINAPRIL HYDROCHLORIDE
quinapril hydrochloride
TABLET;ORAL 078457 ANDA Camber Pharmaceuticals, Inc. 31722-267 31722-267-90 24 BOTTLE in 1 CASE (31722-267-90) > 90 TABLET in 1 BOTTLE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 5MG BASE
Approval Date:Aug 24, 2007TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 10MG BASE
Approval Date:Aug 24, 2007TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 20MG BASE
Approval Date:Aug 24, 2007TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Colorcon
Chinese Patent Office
Mallinckrodt
McKinsey
US Army
Novartis
McKesson
Cantor Fitzgerald
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot